GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
12.8896 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, HSD17B1, KIT, MET, MIF, PPARA, PTGS2, SOAT1, SOAT2 |
12.5223 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FUT7, GLO1, IDO1, MIF, NISCH, PIM1, PPARA, PTGS2, SOAT1, SOAT2, XDH |
11.1283 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
10.4896 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS2 |
9.45377 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, FABP3, FABP4, FUT7, KIT, MET, MIF, PPARA, PTGS2, SOAT1, SOAT2 |
9.3795 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, ALOX15, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
9.3795 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS2 |
9.23757 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
9.02891 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CBR1, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
9.02891 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
9.00747 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, HSD17B1, SOAT1, SOAT2 |
8.9467 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CBR1, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
8.9467 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FLT3, HSD17B1, KDR, KIT, MAOA, MET, MIF, NISCH, PPARA, PTGS2, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, XDH |
8.28107 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
8.18893 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, KIT, MET, SRC |
8.06559 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, GLO1, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
8.02228 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, KIT, MET, SRC |
8.02228 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, GLO1, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
8.02228 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, KDR, KIT, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
8.02228 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, KDR, KIT, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.99369 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK3, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, KIT, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS2, TOP2A |
7.92298 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
7.76695 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS2 |
7.74687 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, CDC25B, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, IDO1, IGF1R, KDR, KIT, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
7.42719 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MIF, MMP9, NISCH, PTGS2, SRC, TERT |
7.13927 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, F3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, NISCH, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
7.09576 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PTGS2 |
7.09576 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AURKB, CDC25B, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
7.09228 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, F3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, NISCH, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
6.98306 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, IDO1, MAOA, PTGS2, XDH |
6.98306 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
6.97608 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
6.86915 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
6.86078 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK3, ESR1, F3, FLT3, GLO1, IDO1, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
6.79748 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MIF, MMP9, NISCH, PTGS2, SRC, TERT |
6.79707 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.77137 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
6.72252 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, IDO1, IGF1R, MMP2, MMP9, PPARA, PTGS2, RORC, SRC |
6.68953 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
6.66085 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, IDO1, MIF, PPARA, PTGS2 |
6.66085 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, GLO1, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
6.64101 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APEX1, APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PTGS2, PTPN1, PTPRS, SRC, TNKS, XDH |
6.59101 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
6.53007 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, MAOA, SOAT1, SOAT2 |
6.53007 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, GLO1, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
6.49384 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALOX15, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, IDO1, IGF1R, KDR, KIT, MMP2, PPARA, PTGS2, RORC, SRC |
6.43841 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
6.40351 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MIF, MMP9, NISCH, PTGS2, SRC, TERT |
6.33409 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MIF, MMP9, NISCH, PTGS2, SRC, TERT |
6.31643 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, IDO1, IGF1R, KDR, KIT, MMP2, MMP9, PPARA, PTGS2, RORC, SRC, TERT |
6.29985 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APEX1, APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PTGS2, PTPN1, PTPRS, SRC, TNKS, XDH |
6.19836 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
6.19013 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, IDO1, MAOA |
6.19013 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CSNK2A1, CYP1B1, DRD2, F3, FLT3, KDR, KIT, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.15131 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, PTGS2, RORC, SRC |
6.05928 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, F3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
5.98228 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, ALOX15, APP, CA2, CYP1A1, CYP1A2, DRD2, FABP4, KIT, MMP9, PTGS2, TERT |
5.88075 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CLK1, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
5.81762 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.80501 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DRD2, DYRK1A, DYRK3, ESR1, F3, FABP4, IDO1, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
5.75387 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, IGF1R, KIT, MMP2, PPARA, PTGS2, SRC |
5.72167 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CSNK2A1, CYP1B1, DRD2, ESRRA, F3, FABP4, FLT3, IDO1, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.71165 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, SRC, TNKS, TOP2A |
5.70145 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, IGF1R, KDR, KIT, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT |
5.65814 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
5.56117 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
5.40878 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.39804 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK2, F3, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, NISCH, PPARA, PTGS2, PTPN1, SRC, TERT |
5.17062 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, APP, AXL, CBR1, CDC25B, CYP1A1, DRD1, DRD2, DYRK3, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, KIT, MET, MIF, MMP2, MMP9, PTGS2, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TOP2A |
5.17062 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, GLO1, IDO1, IGF1R, KDR, MIF, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
5.11947 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CYP1B1, DRD2, F3, FLT3, KDR, KIT, MET, MIF, PTGS2, PTPN1, SRC, XDH |
5.06685 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F3, FLT3, FUT7, GLO1, HASPIN, IDO1, IGF1R, KDR, KIT, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A, XDH |
5.06685 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, APEX1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
5.04494 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALOX15, APEX1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PTGS2, RORC, SRC, TERT |
5.01828 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
4.98043 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PTGS2, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A |
4.82498 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
4.82457 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DYRK1A, DYRK2, DYRK3, ESR1, ESR2, F3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
4.82457 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, IDO1, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.72419 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DYRK2, ESR1, FABP4, FLT3, IGF1R, KDR, KIT, MIF, MMP2, MMP9, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A |
4.64413 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, HASPIN, TERT, TNKS, TNKS2 |
4.6245 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, IDO1, PTGS2, RORC, SRC |
4.58883 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, APEX1, APP, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, PTGS2, RORC, SRC |
4.58497 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2, NISCH |
4.52083 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DYRK1A, ESR1, KIT, PPARA, RORC, SRC, TOP2A |
4.47263 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALOX15, APEX1, APP, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, PTGS2, RORC, SRC |
4.42113 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, CYP19A1, DRD1, DRD2, DYRK1A, DYRK3, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
4.41031 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, PTGS2 |
4.41031 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, SRC |
4.37726 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, PPARA, PTGS2, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A |
4.37603 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F3, FABP4, IDO1, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RORC, SOAT1, SOAT2, SRC, TNKS2 |
4.27772 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, KIT, NISCH, PTGS2 |
4.27772 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, KIT, NISCH, PTGS2 |
4.27772 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, GLO1, IDO1 |
4.2731 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, KDR, MIF, PTGS2, SRC, TNKS, TNKS2 |
4.22398 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, IDO1, KDR, MET, MIF, MMP12, PPARA, PTGS2, PTPRS |
4.19249 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.11944 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DRD1, DRD2, DYRK1A, DYRK3, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
4.11785 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DRD1, DRD2, DYRK1A, DYRK3, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
4.10043 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, PTGS2 |
4.08255 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD1, DRD2, MAOA |
4.0026 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.91859 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, PTGS2 |
3.89468 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.88967 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AKR1C3, ALOX15, APEX1, APP, AURKB, CA9, CDC25B, CLK1, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.87813 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DYRK1A, DYRK3, ESR1, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.87813 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APEX1, APP, AURKB, CA9, CDC25B, CLK1, CSNK2A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.80842 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, PTGS2 |
3.80842 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, MET, SOAT1, SOAT2, SRC, TERT |
3.7751 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.75387 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.75387 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.75387 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.71955 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD2, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PPARA, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A |
3.71461 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, PTGS2, RORC, SRC |
3.69276 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, ALOX15, APEX1, APP, AURKB, CA9, CDC25B, CLK1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.66119 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CYP1A1, FABP3, FLT3, KIT, PPARA, PTGS2, RORC, SRC |
3.62545 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.58349 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, F3, KIT, MET, SRC, XDH |
3.57988 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
3.55928 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.55577 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.55577 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, IDO1, IGF1R, KDR, KIT, MIF, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A |
3.50809 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.48471 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.48471 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
3.45442 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, KIT, MMP9, TERT |
3.43374 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALOX15, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, ESR1, ESRRA, ESRRB, FLT3, KDR, KIT, MMP9, PIM1, PPARA, PTGS2, PTPRS, RORC, SRC |
3.38629 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, PTGS2, TNKS, TNKS2 |
3.38629 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.38093 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.38093 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.38093 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, KDR, KIT, PPARA, PTPRS, SRC |
3.37522 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, CA9, CDC25B, CLK1, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.368 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.3645 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.28631 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD17B1 |
3.28007 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.26606 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.23242 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, IGF1R, KDR, KIT, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.22644 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD17B1 |
3.21373 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, FLT3, KDR, KIT, MIF, PTPN1, SRC, XDH |
3.19986 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
3.1972 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, PTGS2 |
3.1972 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, SRC |
3.16701 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, RORC |
3.15462 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, KDR, PTGS2, SRC |
3.15257 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.10359 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.10359 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, DRD2, ESRRB, FLT3, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.10044 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK2, IDO1, KIT, MIF, MMP2, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, TOP2A |
3.09081 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, APEX1, APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GLO1, HASPIN, IDO1, IGF1R, KDR, KIT, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.07293 |
[BP] GO:0010907 |
None
|
DYRK2, ESRRB, PPARA, SRC |
3.02549 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CYP1B1, MMP9, PTGS2, SRC |
3.02411 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC, TERT |
3.02332 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, IDO1, MIF, PTGS2 |
3.00518 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, DYRK1B, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, MMP12, PPARA, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
3.00207 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
2.99696 |
[BP] GO:0019371 |
None
|
AKR1C3, CBR1, PTGS2 |
2.99209 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
2.98159 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, CLK1, CYP1A1, ESR1, FLT3, KIT, MET, MIF, PIM1, SRC |
2.97882 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, CA9, CDC25B, CLK1, CSNK2A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.97377 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD2, MIF, NISCH |
2.97377 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.97109 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.96087 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC, TERT |
2.95609 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, MIF, PTGS2 |
2.93853 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.9171 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, SRC |
2.9171 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.89595 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, ESR1, FABP4, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, PTPRS, SRC |
2.89595 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.89595 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGS2 |
2.86967 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP1B1, CYP3A4, SOAT1, SOAT2 |
2.86749 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
DRD2, DYRK1A, DYRK3, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, PTPRS, SRC, TERT, XDH |
2.85572 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, CSNK2A1, DRD2, DYRK1A, ESR1, F3, FLT3, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SOAT1, SRC, XDH |
2.85572 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
CLK1, CSNK2A1, DYRK1A, HASPIN, TNKS |
2.85572 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APEX1, APP, AURKB, CSNK2A1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.85572 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD2, MIF, NISCH |
2.85572 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.85572 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.85572 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.85572 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.85572 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.85572 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APEX1, APP, DRD1, ESR1, FLT3, IGF1R, KIT, MMP2, PTGS2, SRC |
2.85565 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, KDR, PTGS2, SRC |
2.83961 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, MIF, SRC, TERT |
2.83961 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
2.81381 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7, MIF |
2.78237 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, KDR, SRC |
2.7766 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, APP, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, IDO1, KIT, MMP2, MMP9, PTGS2, SRC, TOP2A |
2.76601 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, KIT, PTGS2 |
2.76363 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, DRD2, FLT3, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.76348 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SRC, TERT |
2.75618 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.74511 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.74497 |
[BP] GO:0043518 |
None
|
DYRK1A, DYRK3, MIF |
2.74497 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
CLK1, CSNK2A1, DYRK1A, HASPIN, TNKS |
2.72515 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD2, MIF, NISCH |
2.71509 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, MIF, SRC, TNKS, TNKS2 |
2.71007 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.70872 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, MIF, MMP12, PTGS2, SRC, TERT |
2.69797 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, FABP4, FLT3, IGF1R, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.69741 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, MAOA |
2.68841 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, MAOA |
2.68841 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.68841 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, FLT3, IGF1R, KDR, KIT, MIF, PTPN1, SRC, XDH |
2.68692 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CYP1B1, DRD2, ESRRB, F3, IDO1, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PTGS2, SRC, TERT |
2.68186 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.67367 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC |
2.65343 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DYRK2, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT |
2.6431 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, KDR, SRC |
2.61515 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, IDO1, MAOA, XDH |
2.61492 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, F3, KIT, MET, SRC |
2.60211 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APEX1, APP, AURKB, CSNK2A1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.60211 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD2, MIF, NISCH |
2.60211 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.60025 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.60025 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.60025 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CYP19A1, DRD2, IDO1, MIF, MMP12, PTPRS |
2.59392 |
[BP] GO:0048167 |
None
|
ADORA1, APP, DRD1, DRD2, KIT, PTGS2 |
2.5804 |
[BP] GO:2000107 |
negative regulation of leukocyte apoptotic process
|
AURKB, AXL, IDO1, MIF |
2.55852 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, KIT, MIF, PTPN1, SRC |
2.54769 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, F3, FLT3, FUT7, HASPIN, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A |
2.54769 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, KIT, MMP2, PPARA, PTGS2, SRC, TERT |
2.54169 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
MIF, MMP9, PTGS2, PTPN1, SRC |
2.54026 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, KIT |
2.53068 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.53068 |
[BP] GO:0010906 |
None
|
DYRK2, ESRRB, PPARA, RORC, SRC |
2.52282 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, APP, AURKB, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, KIT, MET, MIF, MMP9, PTPN1, SRC, TERT, TNKS, XDH |
2.51638 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.50225 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, PPARA, RORC, TOP2A |
2.48417 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC |
2.48068 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.48051 |
[BP] GO:0034435 |
None
|
SOAT1, SOAT2 |
2.48051 |
[BP] GO:0034433 |
None
|
SOAT1, SOAT2 |
2.48051 |
[BP] GO:0034434 |
None
|
SOAT1, SOAT2 |
2.48051 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.48051 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.48051 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.48051 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.47576 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, CLK1, DRD1, DYRK1A, SRC, TNKS |
2.44903 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DYRK1A, DYRK3, IGF1R, MET, MIF, PTGS2, PTPN1, PTPRS, TERT, XDH |
2.449 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, DRD2, ESR1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.43703 |
[BP] GO:0010676 |
None
|
DYRK2, ESRRB, PPARA, SRC |
2.42277 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, KIT |
2.39275 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.39275 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, IGF1R, KIT, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
2.38132 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, IGF1R, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
2.36588 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.35202 |
[BP] GO:0030154 |
cell differentiation
|
AKR1C3, AXL, CBR1, CYP1A1, DYRK3, ESR1, FABP4, FLT3, FUT7, GLO1, KDR, KIT, MMP2, MMP9, PTGS2, RORC, SOAT1, SOAT2, TOP2A |
2.35172 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.35111 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, KIT, MIF, PTPN1, SRC |
2.35111 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TERT |
2.32612 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.32274 |
[BP] GO:1901796 |
None
|
AURKB, CSNK2A1, DYRK1A, DYRK2, DYRK3, MIF |
2.31622 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.31622 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, PPARA, PTGS2, SRC |
2.30814 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, CDC25B, DRD2, DYRK1A, FLT3, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.3072 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.29761 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, AKR1C3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DYRK1B, DYRK2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, IGF1R, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A |
2.29761 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP2A6, CYP3A4, IDO1, MAOA, XDH |
2.28821 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, DYRK2, F3, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2 |
2.28821 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DRD2, PPARA |
2.28625 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, IDO1, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PTGS2, PTPRS, SRC, TERT, TNKS2, XDH |
2.28269 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, FLT3, FUT7, GLO1, KIT, MMP9, RORC |
2.28099 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, MET, SOAT1, SOAT2 |
2.25635 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.24758 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.24758 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, CA2, CYP19A1, DRD2, ESR1, ESRRA, IDO1, KIT, MIF, MMP12, MMP2, PTPN1, PTPRS, SRC |
2.24586 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, PTGS2 |
2.24584 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.24584 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, DRD2, DYRK1A, ESR1, F3, FLT3, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.2421 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP3A4, MAOA |
2.2421 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, CLK1, DRD1, DYRK1A, SRC, TNKS |
2.2421 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.2421 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.2421 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.2421 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2421 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC |
2.23765 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, IDO1, MAOA, SRC, XDH |
2.23691 |
[BP] GO:0051172 |
None
|
APEX1, APP, AURKB, CSNK2A1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, IGF1R, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.23691 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.23567 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DYRK2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, MIF, MMP2, MMP9, NISCH, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
2.22616 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALOX15, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, IDO1, IGF1R, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.22517 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2152 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.21351 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.19169 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, TERT |
2.18743 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, KDR, MIF, PTPN1, SRC |
2.18743 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, KDR, KIT, MIF, MMP1, MMP12, MMP9, SRC |
2.18518 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.17023 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17023 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.16544 |
[BP] GO:0010675 |
None
|
DYRK2, ESRRB, PPARA, RORC, SRC |
2.14961 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, MIF, PPARA, PTPRS |
2.14831 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
F3, FABP4, IDO1, KDR, MET, MIF, PTGS2 |
2.14831 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.14831 |
[BP] GO:0044267 |
cellular protein metabolic process
|
APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, FLT3, FUT7, HASPIN, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A |
2.1416 |
[BP] GO:0006464 |
cellular protein modification process
|
APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, FLT3, FUT7, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A |
2.13148 |
[BP] GO:0036211 |
protein modification process
|
APP, AURKB, AXL, CDC25B, CLK1, CSNK2A1, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, FLT3, FUT7, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2, TOP2A |
2.13148 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.12855 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, GLO1 |
2.12855 |
[BP] GO:0048169 |
None
|
APP, DRD2, KIT |
2.12855 |
[BP] GO:0051179 |
None
|
ABCB1, ACHE, ADORA1, AKR1C3, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, ESR1, FABP3, HASPIN, KIT, MIF, MMP12, MMP9, NISCH, PPARA, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, XDH |
2.12756 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, KDR, MIF, SRC |
2.11782 |
[BP] GO:0042632 |
None
|
FABP3, FABP4, SOAT1, SOAT2 |
2.1075 |
[BP] GO:0055092 |
None
|
FABP3, FABP4, SOAT1, SOAT2 |
2.1075 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.09906 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, CA2, CA7, DRD1, DRD2, MIF, MMP9, PTGS2 |
2.08988 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, CYP3A4, HSD17B1 |
2.08988 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.08988 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.08988 |
[BP] GO:0006693 |
None
|
AKR1C3, MIF, PTGS2 |
2.08988 |
[BP] GO:0006692 |
None
|
AKR1C3, MIF, PTGS2 |
2.08988 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.07738 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.07738 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.07738 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.07738 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.07738 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.07738 |
[BP] GO:0045913 |
None
|
DYRK2, ESRRB, PPARA, SRC |
2.07563 |
[BP] GO:0016125 |
None
|
APP, CYP19A1, CYP1B1, SOAT1, SOAT2 |
2.07142 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.07142 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.05396 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, DYRK1A, FABP4, FLT3, IGF1R, KDR, KIT, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.0532 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.05088 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SRC, XDH |
2.04046 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, IGF1R, MMP2, PTGS2, SRC |
2.03732 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.03732 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.03732 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, FABP4, FLT3, IGF1R, KIT, MIF, PTPN1, SRC, TNKS |
2.0331 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, KIT |
2.01852 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, DRD1, HASPIN |
2.01852 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, MAOA |
2.01852 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.01852 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, CA2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, IDO1, KDR, KIT, MIF, PIM1, PPARA, PTGS2, PTPRS, RORC, SRC, TERT, TNKS2, XDH |
2.01756 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, MIF, PIM1, PTGS2, SRC, TERT, TNKS, TOP2A |
2.00613 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, FUT7, KDR, KIT, MET, MIF, MMP1, MMP12, MMP9, SRC |
2.00272 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.00025 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, AOX1, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CBR1, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HASPIN, IGF1R, KDR, KIT, MAOA, MIF, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
5.17062 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, AOX1, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CA9, CBR1, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HASPIN, IDO1, IGF1R, KDR, KIT, MAOA, MIF, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
5.01245 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK2, DYRK3, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, IDO1, KDR, KIT, MAOA, MIF, MMP2, MMP9, NISCH, PIM1, PTGS2, PTPN1, PTPRS, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.00271 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, APEX1, APP, AURKB, CA4, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HASPIN, IGF1R, KDR, KIT, MAOA, MMP12, MMP2, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
2.7752 |
[CC] GO:0043229 |
intracellular organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, APEX1, APP, AURKB, CA4, CA9, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HASPIN, IDO1, IGF1R, KDR, KIT, MAOA, MMP12, MMP2, NISCH, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
2.4662 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PIM1, PPARA, PTGS2, PTPN1, PTPRS, RORC, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
18.6947 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DYRK2, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, XDH |
16.8465 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FLT3, FUT7, GLO1, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, PTPRS, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, XDH |
16.8182 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.68506 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, TOP2A, XDH |
9.02891 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, IDO1, MAOA, PTGS2, XDH |
8.23878 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, IGF1R, KDR, KIT, MET, SRC |
8.16746 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
8.14933 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PPARA, SRC, TOP2A |
7.63414 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH |
7.63414 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, TOP2A, XDH |
7.63414 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC, SOAT1, SOAT2 |
7.46694 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, PTGS2, SRC |
7.30642 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, PTGS2, SRC |
7.03555 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
6.86915 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
6.86078 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.64902 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, IDO1, PTGS2, SOAT1, SOAT2, SRC, XDH |
6.63348 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.19013 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
5.94212 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC |
5.86246 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, NISCH, PPARA, RORC, SOAT1, SOAT2 |
5.68689 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS2 |
5.56257 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, AOX1, APP, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FABP3, FABP4, FLT3, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, NISCH, PIM1, PTPRS, SOAT1, SOAT2, SRC, TOP2A, TUBB3, XDH |
5.43352 |
[MF] GO:0004712 |
protein serine/threonine/tyrosine kinase activity
|
AURKB, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3 |
5.43352 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
5.26063 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.06685 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.06685 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
4.99663 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC |
4.8825 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.6245 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.50853 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, AOX1, APEX1, APP, AURKB, AXL, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FLT3, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, PTPN1, RORC, SOAT1, SOAT2, SRC, TERT, TOP2A, TUBB3, XDH |
4.45821 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC |
4.41347 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.41031 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FABP3, FABP4, FLT3, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SOAT1, SOAT2, SRC, TOP2A, TUBB3, XDH |
4.25364 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TERT |
4.21358 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
3.95325 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
3.89468 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, HSD17B1, XDH |
3.77506 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.38629 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.3352 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, CSNK2A1, DRD2, DYRK1A, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP9, NISCH, PTGS2, TERT, TOP2A, XDH |
3.31188 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.2676 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.23242 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PIM1, PPARA, PTPN1, SRC |
3.10437 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, F3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC |
3.01138 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, ADORA1, AOX1, APEX1, APP, AURKB, AXL, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DYRK1A, DYRK1B, DYRK2, DYRK3, ESR1, ESR2, ESRRA, ESRRB, FLT3, HASPIN, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, TUBB3, XDH |
2.97377 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PPARA, PTPN1, SRC |
2.8669 |
[MF] GO:0005524 |
ATP binding
|
ABCB1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A |
2.85572 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AOX1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, TUBB3, XDH |
2.85572 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AOX1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, HSD17B1, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, TUBB3, XDH |
2.85572 |
[MF] GO:0034736 |
None
|
SOAT1, SOAT2 |
2.85572 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.85572 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.85572 |
[MF] GO:0004772 |
None
|
SOAT1, SOAT2 |
2.85572 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.85572 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ABCB1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A |
2.75332 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ABCB1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A |
2.72323 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.71509 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ADORA1, APP, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, PTPRS, SRC, TOP2A, TUBB3 |
2.68841 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.48051 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.48051 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.48051 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.35111 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
ABCB1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, TUBB3 |
2.34087 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, HASPIN, PIM1 |
2.2942 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
ABCB1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, TUBB3 |
2.2421 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.2421 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.2421 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.2421 |
[MF] GO:0017076 |
purine nucleotide binding
|
ABCB1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, TUBB3 |
2.2152 |
[MF] GO:0032553 |
ribonucleotide binding
|
ABCB1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SRC, TOP2A, TUBB3 |
2.20889 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.19575 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD17B1 |
2.17909 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.08988 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.07738 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.07738 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.07352 |
[MF] GO:0016740 |
transferase activity
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, FLT3, FUT7, HASPIN, IGF1R, KDR, KIT, MET, PIM1, SOAT1, SOAT2, SRC, TERT, TNKS, TNKS2 |
2.03372 |